Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Joshua Gowin to Humans

This is a "connection" page, showing publications Joshua Gowin has written about Humans.

 
Connection Strength
  
 
 
0.520
  
  1. Sloan ME, Stellern J, Xiao KB, Germeyer A, Gill K, Laputsina V, Mulsant BH, Ngoy A, Nguyen M, Tang VM, Sanches M, Gowin JL. Emotion regulation impairment across psychiatric disorders: a systematic review and meta-analysis. Transl Psychiatry. 2026 May 29; 16(1).
    View in: PubMed
    Score: 0.024
  2. Gowin JL, Sheller CM. How the brain copes with bad times. PLoS Biol. 2026 Apr; 24(4):e3003710.
    View in: PubMed
    Score: 0.024
  3. Gowin JL, Ashar YK, Mcrae K, Sheller CM, Sloan ME. A comparison of a multivariate neural pattern versus amygdala response for regulation of negative emotion. Soc Cogn Affect Neurosci. 2026 01 21; 21(1).
    View in: PubMed
    Score: 0.023
  4. Gowin JL, Stallsmith V, Weldon K, Dooley G, Karoly HC. Effects of legal-market cannabis and alcohol on verbal learning and memory. Psychopharmacology (Berl). 2026 Apr; 243(4):805-818.
    View in: PubMed
    Score: 0.023
  5. Gowin JL, Ellingson JM, Karoly HC, Manza P, Ross JM, Sloan ME, Tanabe JL, Volkow ND. Brain Function Outcomes of Recent and Lifetime Cannabis Use. JAMA Netw Open. 2025 01 02; 8(1):e2457069.
    View in: PubMed
    Score: 0.022
  6. Gowin JL, Stoddard J, Doykos TK, Sammel MD, Bernert RA. Sleep Disturbance and Subsequent Suicidal Behaviors in Preadolescence. JAMA Netw Open. 2024 09 03; 7(9):e2433734.
    View in: PubMed
    Score: 0.021
  7. Karoly HC, Kirk-Provencher KT, Schacht JP, Gowin JL. Alcohol and brain structure across the lifespan: A systematic review of large-scale neuroimaging studies. Addict Biol. 2024 09; 29(9):e13439.
    View in: PubMed
    Score: 0.021
  8. Kirk-Provencher KT, Sloan ME, Andereas K, Erickson CJ, Hakimi RH, Penner AE, Gowin JL. Neural responses to reward, threat, and emotion regulation and transition to hazardous alcohol use. Alcohol Alcohol. 2024 May 14; 59(4).
    View in: PubMed
    Score: 0.021
  9. Kirk-Provencher KT, Hakimi RH, Andereas K, Penner AE, Gowin JL. Neural response to threat and reward among young adults at risk for alcohol use disorder. Addict Biol. 2024 02; 29(2):e13378.
    View in: PubMed
    Score: 0.020
  10. Rieck J, Wrobel J, Porras AR, McRae K, Gowin JL. Neural signatures of emotion regulation. Sci Rep. 2024 01 20; 14(1):1775.
    View in: PubMed
    Score: 0.020
  11. Sloan ME, Sanches M, Tanabe J, Gowin JL. Delay discounting and family history of psychopathology in children ages 9-11. Sci Rep. 2023 12 11; 13(1):21977.
    View in: PubMed
    Score: 0.020
  12. Gowin JL, Sloan ME, Kirk-Provencher KT, Rosenblatt SL, Penner AE, Stangl BL, Byrd ND, Swan JE, Ramchandani VA. Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users. J Psychopharmacol. 2023 09; 37(9):937-941.
    View in: PubMed
    Score: 0.020
  13. Kirk-Provencher KT, Penner AE, McRae K, Gowin JL. Emotion regulation in young adults with family history of harmful alcohol use: A fMRI study. Drug Alcohol Depend. 2023 02 01; 243:109752.
    View in: PubMed
    Score: 0.019
  14. Penner AE, White E, Stoddard J, Gowin JL. The Neural Circuitry of Reward During Sustained Threat. Cogn Affect Behav Neurosci. 2022 02; 22(1):134-144.
    View in: PubMed
    Score: 0.017
  15. Gowin JL, Manza P, Ramchandani VA, Volkow ND. Neuropsychosocial markers of binge drinking in young adults. Mol Psychiatry. 2021 09; 26(9):4931-4943.
    View in: PubMed
    Score: 0.016
  16. Tanabe J, Regner M, Sakai J, Martinez D, Gowin J. Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment. Br J Radiol. 2019 Sep; 92(1101):20180942.
    View in: PubMed
    Score: 0.015
  17. Gowin JL, Ernst M, Ball T, May AC, Sloan ME, Tapert SF, Paulus MP. Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models. Neuroimage Clin. 2019; 21:101676.
    View in: PubMed
    Score: 0.014
  18. Gowin J, Sloan ME, Swan JE, Momenan R, Ramchandani VA. The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology. Psychopharmacology (Berl). 2019 Feb; 236(2):775-785.
    View in: PubMed
    Score: 0.014
  19. Gowin JL, Sloan ME, Ramchandani VA, Paulus MP, Lane SD. Differences in decision-making as a function of drug of choice. Pharmacol Biochem Behav. 2018 01; 164:118-124.
    View in: PubMed
    Score: 0.013
  20. Gowin JL, Sloan ME, Stangl BL, Vatsalya V, Ramchandani VA. Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption. Am J Psychiatry. 2017 11 01; 174(11):1094-1101.
    View in: PubMed
    Score: 0.013
  21. Gowin JL, Vatsalya V, Westman JG, Schwandt ML, Bartlett S, Heilig M, Momenan R, Ramchandani VA. The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers. Alcohol Clin Exp Res. 2016 05; 40(5):979-87.
    View in: PubMed
    Score: 0.012
  22. Gowin JL, Ball TM, Wittmann M, Tapert SF, Paulus MP. Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse. Drug Alcohol Depend. 2015 Jul 01; 152:93-101.
    View in: PubMed
    Score: 0.011
  23. Gowin JL, Harlé KM, Stewart JL, Wittmann M, Tapert SF, Paulus MP. Attenuated insular processing during risk predicts relapse in early abstinent methamphetamine-dependent individuals. Neuropsychopharmacology. 2014 May; 39(6):1379-87.
    View in: PubMed
    Score: 0.010
  24. Gowin JL, Stewart JL, May AC, Ball TM, Wittmann M, Tapert SF, Paulus MP. Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact. Addiction. 2014 Feb; 109(2):237-47.
    View in: PubMed
    Score: 0.010
  25. Gowin JL, Mackey S, Paulus MP. Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):13-21.
    View in: PubMed
    Score: 0.010
  26. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. The role of cortisol and psychopathy in the cycle of violence. Psychopharmacology (Berl). 2013 Jun; 227(4):661-72.
    View in: PubMed
    Score: 0.010
  27. Gowin JL, Green CE, Alcorn JL, Swann AC, Moeller FG, Lane SD. Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior. J Psychopharmacol. 2012 Jul; 26(7):982-93.
    View in: PubMed
    Score: 0.009
  28. Gowin JL, Swann AC, Moeller FG, Lane SD. Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology (Berl). 2010 Jul; 210(4):521-31.
    View in: PubMed
    Score: 0.008
  29. Lane SD, Gowin JL. GABAergic modulation of human social interaction in a prisoner's dilemma model by acute administration of alprazolam. Behav Pharmacol. 2009 Oct; 20(7):657-61.
    View in: PubMed
    Score: 0.008
  30. Gelino BW, Felton JW, Hung IT, Strickland JC, Kahn GD, Thomas NS, Gowin JL, Sloan ME, Palmer AA, Sanchez-Roige S, Sanches MR, Yip SW, Maher BS, Rabinowitz JA. Delay discounting violations vary by adolescent sociodemographics: Excluding nonsystematic data may bias conclusions. Exp Clin Psychopharmacol. 2026 Feb; 34(1):31-43.
    View in: PubMed
    Score: 0.006
  31. Frank GKW, Stoddard JJ, Brown T, Gowin J, Kaye WH. Weight gained during treatment predicts 6-month body mass index in a large sample of patients with anorexia nervosa using ensemble machine learning. Int J Eat Disord. 2024 Aug; 57(8):1653-1667.
    View in: PubMed
    Score: 0.005
  32. Stellern J, Xiao KB, Grennell E, Sanches M, Gowin JL, Sloan ME. Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction. 2023 01; 118(1):30-47.
    View in: PubMed
    Score: 0.005
  33. Janakiraman R, Gowin JL, Sloan ME, Schwandt ML, Diazgranados N, Ramchandani VA, Kwako LE. History of suicidality and alcohol craving trajectories during inpatient treatment for alcohol use disorder. Drug Alcohol Depend. 2020 04 01; 209:107918.
    View in: PubMed
    Score: 0.004
  34. Regner MF, Tregellas J, Kluger B, Wylie K, Gowin JL, Tanabe J. The insula in nicotine use disorder: Functional neuroimaging and implications for neuromodulation. Neurosci Biobehav Rev. 2019 08; 103:414-424.
    View in: PubMed
    Score: 0.004
  35. Sloan ME, Gowin JL, Janakiraman R, Ester CD, Stoddard J, Stangl B, Ramchandani VA. High-risk social drinkers and heavy drinkers display similar rates of alcohol consumption. Addict Biol. 2020 03; 25(2):e12734.
    View in: PubMed
    Score: 0.004
  36. Sloan ME, Grant CW, Gowin JL, Ramchandani VA, Le Foll B. Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies. Acta Pharmacol Sin. 2019 Mar; 40(3):342-350.
    View in: PubMed
    Score: 0.004
  37. Sloan ME, Klepp TD, Gowin JL, Swan JE, Sun H, Stangl BL, Ramchandani VA. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption. Neuropsychopharmacology. 2018 06; 43(7):1530-1538.
    View in: PubMed
    Score: 0.003
  38. Sloan ME, Gowin JL, Ramchandani VA, Hurd YL, Le Foll B. The endocannabinoid system as a target for addiction treatment: Trials and tribulations. Neuropharmacology. 2017 Sep 15; 124:73-83.
    View in: PubMed
    Score: 0.003
  39. Sloan ME, Gowin JL, Yan J, Schwandt ML, Spagnolo PA, Sun H, Hodgkinson CA, Goldman D, Ramchandani VA. Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant. Addict Biol. 2018 01; 23(1):474-484.
    View in: PubMed
    Score: 0.003
  40. Pariyadath V, Gowin JL, Stein EA. Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks. Prog Brain Res. 2016; 224:155-73.
    View in: PubMed
    Score: 0.003
  41. Vatsalya V, Gowin JL, Schwandt ML, Momenan R, Coe MA, Cooke ME, Hommer DW, Bartlett S, Heilig M, Ramchandani VA. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers. Int J Neuropsychopharmacol. 2015 Jul 25; 18(12).
    View in: PubMed
    Score: 0.003
  42. Kose S, Steinberg JL, Moeller FG, Gowin JL, Zuniga E, Kamdar ZN, Schmitz JM, Lane SD. Neural correlates of impulsive aggressive behavior in subjects with a history of alcohol dependence. Behav Neurosci. 2015 Apr; 129(2):183-96.
    View in: PubMed
    Score: 0.003
  43. Alcorn JL, Gowin JL, Green CE, Swann AC, Moeller FG, Lane SD. Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder. J Neuropsychiatry Clin Neurosci. 2013; 25(3):229-32.
    View in: PubMed
    Score: 0.002
  44. Lane SD, Gowin JL, Green CE, Steinberg JL, Moeller F, Cherek DR. Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior. Pharmacol Biochem Behav. 2009 Apr; 92(2):357-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)